Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years | Zendy

Carla Vizzotti | Zendy; Jorge González | Zendy; Analía Rearte | Zendy; Analía Urueña | Zendy; María Pérez Carrega | Zendy; Rogelio Calli | Zendy; Ángela Gentile | Zendy; Andrea Uboldi | Zendy; Margarita Ramonet | Zendy; María Cristina Cañero-Velasco | Zendy; Máximo Diosque | Zendy

Open Access

Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years

Author(s) -

Carla Vizzotti,

Jorge González,

Analía Rearte,

Analía Urueña,

María Pérez Carrega,

Rogelio Calli,

Ángela Gentile,

Andrea Uboldi,

Margarita Ramonet,

María Cristina Cañero-Velasco,

Máximo Diosque

Publication year - 2014

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piu068

Subject(s) - medicine , confidence interval , seroprevalence , antibody , vaccination , odds ratio , hepatitis a , immunology , hepatitis , serology

Single-dose hepatitis A virus (HAV) vaccination was implemented in all Argentinean children aged 12 months in 2005. Between 2005 and 2011, a dramatic decline was observed in HAV infection rates, fulminant hepatitis, and liver transplantation. This study assessed current viral circulation and estimated protective antibody persistence 4 years after vaccination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research